SCHEMBL2931955

SCHEMBL2931955

O=CC#CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20299959 0.75 APLNR (0.60)
Formic Acid SCHEMBL2166067 0.72
SCHEMBL5125793 0.69
SCHEMBL263643 0.67
SCHEMBL10032063 0.67
SCHEMBL3358097 0.67
SCHEMBL3292879 0.67
SCHEMBL3288478 0.67
SCHEMBL2165938 0.65
SCHEMBL821860 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 WO claimed
CN-112135817-A Monomer comprising at least one 4- (2-oxyethylene) -1, 3-dioxolan-2-one unit and use thereof 巴斯夫欧洲公司 2020-12-25 CN claimed
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 WO disclosed
CN-112135817-A Monomer comprising at least one 4- (2-oxyethylene) -1, 3-dioxolan-2-one unit and use thereof 巴斯夫欧洲公司 2020-12-25 CN disclosed
US-20180052161-A1 BIOMARKERS FOR MALARIA DIAGNOSIS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2018-02-22 US disclosed
US-9505765-B2 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment CONFLUENCE LIFE SCIENCES INC. (US) 2016-11-29 US disclosed
WO-2016149386-A1 BIOMARKERS FOR MALARIA DIAGNOSIS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2016-09-22 WO disclosed
US-9219123-B2 Method of producing a nitride semiconductor crystal with precursor containing carbon and oxygen, and nitride semiconductor crystal and semiconductor device made by the method SHARP KABUSHIKI KAISHA (JP) 2015-12-22 US disclosed
US-20150203499-A1 4-ALKOXY/ARALKOXY-5-SUBSTITUTED-PYRROLOPYRIMIDINE COMPOUNDS AS TAK1 INHIBITORS IN DISEASE TREATMENT ACLARIS THERAPEUTICS, INC. 2015-07-23 US disclosed
US-20140145202-A1 NITRIDE SEMICONDUCTOR CRYSTAL SHARP KABUSHIKI KAISHA (JP) 2014-05-29 US disclosed
WO-2014018888-A1 4-ALKOXY/ARALKOXY-5-SUBSTITUTED-PYRROLOPYRIMIDINE COMPOUNDS AS TAK1 INHIBITORS IN DISEASE TREATMENT CONFLUENCE LIFE SCIENCES INC. (US) 2014-01-30 WO disclosed
EP-2230312-A1 Probe compound for detecting and isolating enzymes and means and methods using the same Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2010-09-22 EP disclosed
EP-0562069-B1 METHOD OF PREPARING 3-(S)-FURAN DERIVATIVES GIVAUDAN ROURE INT (CH) 1996-06-19 EP disclosed
EP-0562069-A1 METHOD OF PREPARING 3-(S)-FURAN DERIVATIVES. GIVAUDAN ROURE INT (CH) 1993-09-29 EP disclosed
WO-1993007134-A1 METHOD OF PREPARING 3-(S)-FURAN DERIVATIVES GIVAUDAN-ROURE (INTERNATIONAL) SA (CH) 1993-04-15 WO disclosed
US-4426449-A Method for producing vicinal dihalogenated products CETUS CORPORATION (US) 1984-01-17 US disclosed
EP-0082006-A2 Method for producing vicinal dihalogenated products and uses thereof, and process for preparing epoxides using the same CETUS CORPORATION (US) 1983-06-22 EP disclosed